Advances in the Endoscopic Management of Obesity

Gastroenterology Research and Practice

Volumn 2015, Issue , 2015, Pages

  Behary, Jason ^a   Kumbhari, Vivek ^b  

^a ST GEORGE HOSPITAL   (Australia)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ASPIRATION THERAPY; BARIATRIC SURGERY; BODY MASS; DIGESTIVE IMPLANT; DUODENAL JEJUNAL BYPASS LINER; ELECTROSTIMULATION; ENDOSCOPIC THERAPY; FOLLOW UP; GASTRIC BALLOON; GASTRIC ELECTRICAL STIMULATION; HEALTH CARE COST; HUMAN; MINIMALLY INVASIVE PROCEDURE; MORBIDITY; MORTALITY; OBESITY; QUALITY OF LIFE; REVIEW; ROUX Y ANASTOMOSIS; STOMACH EMPTYING; TRANSORAL ENDOSCOPIC RESTRICTIVE IMPLANT SYSTEM; TRANSPYLORIC SHUTTLE; WEIGHT REDUCTION;

EID: 84935856369     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2015/757821     Document Type: Review

References (69)

1. K. M. Flegal, M. D. Carroll, B. K. Kit, and C. L. Ogden, "Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010", The Journal of the American Medical Association, vol. 307, no. 5, pp. 491-497, 2012.
2. C. L. Ogden, M. D. Carroll, and K. M. Flegal, "Prevalence of obesity in the United States", JAMA, vol. 312, no. 2, pp. 189-190, 2014.
3. R. Sturmand A. Hattori, "Morbid obesity rates continue to rise rapidly in the United States", International Journal of Obesity, vol. 37, no. 6, pp. 889-891, 2013.
4. A. H. Mokdad, E. S. Ford, B. A. Bowman et al., "Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001", The Journal of the American Medical Association, vol. 289, no. 1, pp. 76-79, 2003.
5. T. A. Wadden and D. L. Frey, "A multicenter evaluation of a proprietary weight loss program for the treatment of marked obesity: a five-year follow-up", International Journal of Eating Disorders, vol. 22, no. 2, pp. 203-212, 1997.
6. T. A. Wadden, R. H. Neiberg, R. R. Wing et al., "Four-year weight losses in the look AHEAD study: factors associated with long-term success", Obesity, vol. 19, no. 10, pp. 1987-1998, 2011.
7. V. L. Gloy, M. Briel, D. L. Bhatt et al., "Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials", British Medical Journal, vol. 347, Article ID f5934, 2013.
8. Z. Li, M. Maglione, W. Tu et al., "Meta-analysis: pharmacologic treatment of obesity", Annals of Internal Medicine, vol. 142, no. 7, pp. 532-546, 2005.
9. T. A. Wadden, R. I. Berkowitz, L. G. Womble et al., "Randomized trial of lifestyle modification and pharmacotherapy for obesity", The New England Journal of Medicine, vol. 353, no. 20, pp. 2111-2120, 2005.
10. "Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. National institutes of health", Obesity Research, vol. 6, supplement 2, pp. 51S-209S, 1998.
11. R. Padwal, S. Klarenbach, N. Wiebe et al., "Bariatric surgery: a systematic review and network meta-analysis of randomized trials", Obesity Reviews, vol. 12, no. 8, pp. 602-621, 2011.
12. H. Buchwald, R. Estok, K. Fahrbach et al., "Weight and type 2 diabetes after bariatric surgery: systematic review and metaanalysis", American Journal of Medicine, vol. 122, no. 3, pp. 248.e5-256.e5, 2009.
13. W. J. Pories, "Bariatric surgery: risks and rewards", Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 11, supplement 1, pp. s89-s96, 2008.
14. K. R. Dumon and K. M. Murayama, "Bariatric surgery outcomes", Surgical Clinics of North America, vol. 91, no. 6, pp. 1313-1338, 2011.
15. T. D. Adams, R. E. Gress, S. C. Smith et al., "Long-term mortality after gastric bypass surgery", The New England Journal of Medicine, vol. 357, no. 8, pp. 753-761, 2007.
16. H. Buchwald, Y. Avidor, E. Braunwald et al., "Bariatric surgery: a systematic review and meta-analysis", The Journal of the American Medical Association, vol. 292, no. 14, pp. 1724-1737, 2004.
17. M. K. Robinson, "Surgical treatment of obesity-weighing the facts", The New England Journal of Medicine, vol. 361, no. 5, pp. 520-521, 2009.
18. M. Morino, M. Toppino, P. Forestieri, L. Angrisani, M. E. Allaix, and N. Scopinaro, "Mortality after bariatric surgery: analysis of 13,871 morbidly obese patients from a national registry", Annals of Surgery, vol. 246, no. 6, pp. 1002-1007, 1009, 2007.
19. D. O. Magro, B. Geloneze, R. Delfini, B. C. Pareja, F. Callejas, and J. C. Pareja, "Long-term weight regain after gastric bypass: a 5-year prospective study", Obesity Surgery, vol. 18, no. 6, pp. 648-651, 2008.
20. R. E. Brolin, "Bariatric surgery and long-termcontrol of morbid obesity", Journal of the American Medical Association, vol. 288, no. 22, pp. 2793-2796, 2002.
21. J. E. Mitchell, K. L. Lancaster, M. A. Burgard et al., "Longterm follow-up of patients' status after gastric bypass", Obesity Surgery, vol. 11, no. 4, pp. 464-468, 2001.
22. M. Anderson, S. Gan, and R. Fanelli, "ASGE Standards of Practice Committee. Role of endoscopy in the bariatric surgery patients", Gastrointestinal Endoscopy, vol. 68, pp. 1-10, 2008.
23. J. G. Dillon and M. K. Hughes, "Degradation of five polyurethane gastric bubbles following in vivo use: SEC, ATR-IR and DSC studies", Biomaterials, vol. 13, no. 4, pp. 240-248, 1992.
24. R. B. Hogan, J. H. Johnston, B. W. Long et al., "A doubleblind, randomized, sham-controlled trial of the gastric bubble for obesity", Gastrointestinal Endoscopy, vol. 35, no. 5, pp. 381-385, 1989.
25. D. F. Kirby, J. B. Wade, P. R. Mills et al., "A prospective assessment of the Garren-Edwards Gastric Bubble and bariatric surgery in the treatment of morbid obesity", The American Surgeon, vol. 56, no. 10, pp. 575-580, 1990.
26. S. B. Benjamin, K. A. Maher, E. L. Cattau Jr. et al., "Doubleblind controlled trial of the Garren-Edwards gastric bubble: an adjunctive treatment for exogenous obesity", Gastroenterology, vol. 95, no. 3, pp. 581-588, 1988.
27. G. Galloro, G. D. de Palma, C. Catanzano et al., "Preliminary endoscopic technical report of a new silicone intragastric balloon in the treatment ofmorbidobesity", Obesity Surgery, vol. 9, no. 1, pp. 68-71, 1999.
28. I. Imaz, C. Martínez-Cervell, E. E. García-Álvarez, J. M. Sendra-Gutiérrez, and J. González-Enríquez, "Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis", Obesity Surgery, vol. 18, no. 7, pp. 841-846, 2008.
29. J.-M. Dumonceau, "Evidence-based review of the bioenterics intragastric balloon for weight loss", Obesity Surgery, vol. 18, no. 12, pp. 1611-1617, 2008.
30. A. Genco, T. Bruni, S. B. Doldi et al., "Bio Enterics intragastric balloon: the Italian experience with 2,515 patients", Obesity Surgery, vol. 15, no. 8, pp. 1161-1164, 2005.
31. S. Gaur, S. Levy, L. Mathus-Vliegen, and R. Chuttani, "Balancing risk and reward: a critical review of the intragastric balloon for weight loss", Gastrointestinal Endoscopy, vol. 81, no. 6, pp. 1330-1336, 2015.
32. S. N. Dastis, E. François, J. Deviere et al., "Intragastric balloon for weight loss: results in 100 individuals followed for at least 2.5 years", Endoscopy, vol. 41, no. 7, pp. 575-580, 2009.
33. J. Ponce, B. B. Quebbemann, and E. J. Patterson, "Prospective, randomized, multicenter study evaluating safety and efficacy of intragastric dual-balloon in obesity", Surgery for Obesity and Related Diseases, vol. 9, no. 2, pp. 290-295, 2013.
34. A. Genco, D. Dellepiane, G. Baglio et al., "Adjustable intragastric balloon vs non-adjustable intragastric balloon: casecontrol study on complications, tolerance, and efficacy", Obesity Surgery, vol. 23, no. 7, pp. 953-958, 2013.
35. R. van Hee, S. van Wiemeersch, B. Lasters, and J. Weyler, "Use of anti-emetics after intragastric balloon placement: experience with three different drug treatments", Obesity Surgery, vol. 13, no. 6, pp. 932-937, 2003.
36. G. Marinos, C. Eliades, V. Raman Muthusamy, and F. Greenway, "Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3- and 6-month study", Surgery for Obesity and Related Diseases, vol. 10, no. 5, pp. 929-934, 2014.
37. R. Fogel, J. de Fogel, Y. Bonilla, and R. de la Fuente, "Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients", Gastrointestinal Endoscopy, vol. 68, no. 1, pp. 51-58, 2008.
38. S. A. Brethauer, B. Chand, P. R. Schauer, and C. C. Thompson, "Transoral gastric volume reduction as intervention for weight management: 12-month follow-up of TRIM trial", Surgery for Obesity and Related Diseases, vol. 8, no. 3, pp. 296-303, 2012.
39. J. Deviere, G. Ojeda Valdes, L. Cuevas Herrera et al., "Safety, feasibility and weight loss after transoral gastroplasty: first humanmulticenter study", Surgical Endoscopy, vol. 22, no. 3, pp. 589-598, 2008
40. Erratum in: Surgical Endoscopy, vol. 22, no. 3, p. 599, 2008.
41. P. Familiari, G. Costamagna, D. Bléro et al., "Transoral gastroplasty for morbid obesity: a multicenter trial with a 1-year outcome", Gastrointestinal Endoscopy, vol. 74, no. 6, pp. 1248-1258, 2011.
42. B. K. Abu Dayyeh, E. Rajan, and C. J. Gostout, "Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity", Gastrointestinal Endoscopy, vol. 78, no. 3, pp. 530-535, 2013.
43. R. Z. Sharaiha, P. Kedia, N. Kumta et al., "Initial experience with endoscopic sleeve gastroplasty: technical success and reproducibility in the bariatric population", Endoscopy, vol. 47, no. 2, pp. 164-166, 2015.
44. G. Lopez-Nava, M. Galvão, I. da Bautista-Castaño, A. Jimenez, T. de Grado, and J. Fernandez-Corbelle, "Endoscopic sleeve gastroplasty for the treatment of obesity", Endoscopy, vol. 47, no. 5, pp. 449-452, 2015.
45. T. Verlaan, G. F. Paulus, E. M. H. Mathus-Vliegen et al., "Endoscopic gastric volume reduction with a novel articulating plication device is safe and effective in the treatment of obesity (with video)", Gastrointestinal Endoscopy, vol. 81, no. 2, pp. 312-320, 2015.
46. L. Biertho, F.-S. Hould, S. Lebel, and S. Biron, "Transoral endoscopic restrictive implant system: a new endoscopic technique for the treatment of obesity", Surgery for Obesity and Related Diseases, vol. 6, no. 2, pp. 203-205, 2010.
47. A. Legner, A. Altorjay, A. Juhasz et al., "Transoral mucosal excision sutured gastroplasty: a pilot study for GERD and obesity with two-year follow-up", Surgical Innovation, vol. 21, no. 5, pp. 456-463, 2014.
48. L. Rodriguez-Grunert, M. P. Galvao Neto, M. Alamo, A. C. Ramos, P. B. Baez, and M. Tarnoff, "First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve", Surgery for Obesity and Related Diseases, vol. 4, no. 1, pp. 55-59, 2008.
49. M. Tarnoff, L. Rodriguez, A. Escalona et al., "Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for preoperative weight loss in bariatric surgery", Surgical Endoscopy and Other Interventional Techniques, vol. 23, no. 3, pp. 650-656, 2009.
50. K. S. Gersin, R. I. Rothstein, R. J. Rosenthal et al., "Openlabel, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates", Gastrointestinal Endoscopy, vol. 71, no. 6, pp. 976-982, 2010.
51. R. Schouten, C. S. Rijs, N. D. Bouvy et al., "A multicenter, randomized efficacy study of the endobarrier gastrointestinal liner for presurgical weight loss prior to bariatric surgery", Annals of Surgery, vol. 251, no. 2, pp. 236-243, 2010.
52. A. Escalona, F. Pimentel, A. Sharp et al., "Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner", Annals of Surgery, vol. 255, no. 6, pp. 1080-1085, 2012.
53. E. G. H. de Moura, B. C. Martins, G. S. Lopes et al., "Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner", Diabetes Technology and Therapeutics, vol. 14, no. 2, pp. 183-189, 2012.
54. P. Koehestanie, C. de Jonge, F. J. Berends, I. M. Janssen, N. D. Bouvy, and J.W. Greve, "Theeffect of the endoscopic duodenaljejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial", Annals of Surgery, vol. 260, no. 6, pp. 984-992, 2014.
55. S. R. H. Patel, D. Hakim, J. Mason, and N. Hakim, "The duodenal-jejunal bypass sleeve (Endo Barrier Gastrointestinal Liner) for weight loss and treatment of type 2 diabetes", Surgery for Obesity and Related Diseases, vol. 9, no. 3, pp. 482-484, 2013.
56. I. Zechmeister-Koss, M. Huić, and S. Fischer, "The duodenaljejunal bypass liner for the treatment of type 2 diabetes mellitus and/or obesity: a systematic review", Obesity Surgery, vol. 24, no. 2, pp. 310-323, 2014.
57. N. Sauer, T. Rösch, J. Pezold et al., "A new endoscopically implantable device (satisphere) for treatment of obesity-efficacy, safety, and metabolic effects on glucose, insulin, and GLP-1 Levels", Obesity Surgery, vol. 23, no. 11, pp. 1727-1733, 2013.
58. T. L. Peeters, "Potential of ghrelin as a therapeutic approach for gastrointestinal motility disorders", Current Opinion in Pharmacology, vol. 6, no. 6, pp. 553-558, 2006.
59. D. Gui, A. de Gaetano, P. L. Spada, A. Viggiano, E. Cassetta, and A. Albanese, "Botulinum toxin injected in the gastric wall reduces body weight and food intake in rats", Alimentary Pharmacology and Therapeutics, vol. 14, no. 6, pp. 829-834, 2000.
60. G. Albani, M. L. Petroni, A. Mauro et al., "Safety and efficacy of therapy with botulinum toxin in obesity: a pilot study", Journal of Gastroenterology, vol. 40, no. 8, pp. 833-835, 2005.
61. D. García-Compean, E. Mendoza-Fuerte, J. A. Martínez, I. Villarreal, and H. Maldonado, "Endoscopic injection of botulinum toxin in the gastric antrum for the treatment of obesity: results of a pilot study", Gastroentérologie Clinique et Biologique, vol. 29, no. 8-9, pp. 789-791, 2005.
62. A. C. Cardoso Jr., P. R. Savassi-Rocha, L. G. Vaz Coelho et al., "Botulinum A toxin injected into the gastric wall for the treatment of class III obesity: a pilot study", Obesity Surgery, vol. 16, no. 3, pp. 335-343, 2006.
63. D. Foschi, F. Corsi, M. Lazzaroni et al., "Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study", International Journal of Obesity, vol. 31, no. 4, pp. 707-712, 2007.
64. L. Li, Q.-S. Liu, W.-H. Liu et al., "Treatment of obesity by endoscopic gastric intramural injection of botulinumtoxin A: a randomized clinical trial", Hepato-Gastroenterology, vol. 59, no. 118, pp. 2003-2007, 2012.
65. M. Topazian, M. Camilleri, F. T. Enders et al., "Gastric antral injections of botulinumtoxin delay gastric emptying but do not reduce body weight", Clinical Gastroenterology and Hepatology, vol. 11, no. 2, pp. 145-150, 2013.
66. H. S. Sallam, J. D. Z. Chen, and P. J. Pasricha, "Feasibility of gastric electrical stimulation by percutaneous endoscopic transgastric electrodes", Gastrointestinal Endoscopy, vol. 68, no. 4, pp. 754-759, 2008.
67. X. Xu, P. J. Pasricha, and J.D. Z. Chen, "Feasibilityof gastric electrical stimulation by use of endoscopically placed electrodes", Gastrointestinal Endoscopy, vol. 66, no. 5, pp. 981-986, 2007.
68. Y. Zhang, S. Du, L. Fang, S. Yao, and J. D. Z. Chen, "Retrograde gastric electrical stimulation suppresses calorie intake in obese subjects", Obesity, vol. 22, no. 6, pp. 1447-1451, 2014.
69. S. Sullivan, R. Stein, S. Jonnalagadda, D. Mullady, and S. Edmundowicz, "Aspiration therapy leads to weight loss in obese subjects: a pilot study", Gastroenterology, vol. 145, no. 6, pp. 1245-e5, 2013.